Buy & Sell American Airlines Group Inc (AAL) – American Airlines Group Inc Price Today
Aura AI Summary
Key Stats
- $8.56BMarket Cap
- IndustrialsSector
- -32.58%3M Drawdown
- $36.16BEnterprise Value
- -Dividend Yield
- 21% Buy | 79% SellTrading Activity
- 55 daysTypical Hold Time
American Airlines Group Inc (AAL) is currently valued at a market capitalization of $8.56B, with an enterprise value of $36.16B. Over the past 52 weeks, American Airlines Group Inc has traded between a low of $10.18 and a high of $16.26, highlighting its annual price range. Over the past three months, American Airlines Group Inc has recorded a drawdown of -32.58%, reflecting recent price volatility. On average, investors hold American Airlines Group Inc for approximately 55 days, indicating typical investor behavior on the platform.
About American Airlines Group Inc
American Airlines is the world's largest airline by scheduled revenue passenger miles. The firm's major hubs are Charlotte, Chicago, Dallas/Fort Worth, Los Angeles, Miami, New York, Philadelphia, Phoenix, and Washington, D.C. After completing a major fleet renewal, the company has the youngest fleet of U.S. legacy carriers.
Most Recent News
Incannex Healthcare wins award for innovative drug IHL-42X treating obstructive sleep apnea.
Incannex Healthcare has been recognized by MedTech Breakthrough with the "Best New Technology Solution for Drug Development" award for its lead drug candidate IHL-42X, an oral combination therapy for obstructive sleep apnea (OSA). IHL-42X combines dr...
Fredonia expands El Dorado–Monserrat gold-silver district by 50%, acquiring 11,754 hectares from Pan American Silver.
Fredonia Mining Inc. has acquired approximately 11,754 hectares of mineral properties from a Pan American Silver subsidiary, expanding its El Dorado–Monserrat (EDM) gold-silver project in Argentina to about 33,500 hectares—a 50% increase. This acquis...
Medical marijuana market set to exceed $130B by 2030, driven by legalization and rising demand.
The global medical marijuana market is rapidly growing, expected to reach over $130 billion by the early to mid-2030s due to expanding legalization, increased clinical adoption, and rising demand for non-opioid treatments. Companies like Herbal Dispa...